Daunorubicin and cytarabine with daunorubicin cytarabine and the MDR1 reversal agent PSC-833 in elderly patients with acute myelogenous leukemia

B Van der Holt, P Sonneveld, AK Burnett, PJM Vossebeld, B Beverloo, G Rosenkranz, M Dugan, WLJ Van Putten, Keith Wheatley, B Lowenberg

Research output: Contribution to journalAbstract

Original languageEnglish
Pages (from-to)11
Number of pages1
Publication statusPublished - 1 Jan 2004

Cite this